{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Curcuma longa", "Momordica charantia", "berberine", "cinnamon", "fenugreek", "medicinal plant", "type 2 diabetes mellitus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37111272", "DateRevised": {"Year": "2023", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "30"}], "Language": ["eng"], "ELocationID": ["515", "10.3390/ph16040515"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "30"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Role of Fenugreek, Cinnamon, <i>Curcuma longa</i>, Berberine and <i>Momordica charantia</i> in Type 2 Diabetes Mellitus Treatment: A Review.", "Abstract": {"AbstractText": ["Type 2 diabetes mellitus (T2DM) is a complex disease that has become a major global health concern. Given the efficacy of antidiabetic drugs, pharmacological therapy is considered the first-line treatment of T2DM; however, due to their potential side effects and high costs, new and cost-effective treatments with minimal side effects are needed. Medicinal plants have been used for centuries as part of traditional medicine to treat T2DM. Among these, fenugreek, cinnamon, <i>Curcuma longa</i>, berberine, and <i>Momordica charantia</i> have demonstrated different degrees of hypoglycemic activity in clinical studies and animal models. Therefore, the aim of this review is to synthesize the mechanisms of action of five medicinal plants, as well as the experimental and clinical evidence of their hypoglycemic activity from the published literature."]}, "AuthorList": [{"Identifier": ["0000-0002-8875-7483"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Science University Center, University of Guadalajara, Sierra Mojada 950, Col. Independencia, Guadalajara 44340, Jalisco, Mexico."}], "LastName": "Cortez-Navarrete", "ForeName": "Marisol", "Initials": "M"}, {"Identifier": ["0000-0003-1767-1719"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Science University Center, University of Guadalajara, Sierra Mojada 950, Col. Independencia, Guadalajara 44340, Jalisco, Mexico."}], "LastName": "P\u00e9rez-Rubio", "ForeName": "Karina G", "Initials": "KG"}, {"Identifier": ["0000-0001-5498-2458"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Science University Center, University of Guadalajara, Sierra Mojada 950, Col. Independencia, Guadalajara 44340, Jalisco, Mexico."}], "LastName": "Escobedo-Guti\u00e9rrez", "ForeName": "Miriam de J", "Initials": "MJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Petersmann A., M\u00fcller-Wieland D., M\u00fcller U.A., Landgraf R., Nauck M., Freckmann G., Heinemann L., Schleicher E. Definition, classification and diagnosis of diabetes mellitus. Exp. Clin. Endocrinol. Diabetes. 2019;127:S1\u2013S7. doi: 10.1055/a-1018-9078.", "ArticleIdList": ["10.1055/a-1018-9078", "31860923"]}, {"Citation": "Chatterjee S., Khunti K., Davies M.J. Type 2 diabetes. Lancet. 2017;389:2239\u20132251. doi: 10.1016/S0140-6736(17)30058-2.", "ArticleIdList": ["10.1016/S0140-6736(17)30058-2", "28190580"]}, {"Citation": "ElSayed N.A., Aleppo G., Aroda V.R., Bannuru R.R., Brown F.M., Bruemmer D., Collins B.S., Cusi K., Das S.R., Gibbons C.H., et al. Introduction and methodology: Standards of care in diabetes-2023. Diabetes Care. 2023;46:S1\u2013S4. doi: 10.2337/dc23-Sint.", "ArticleIdList": ["10.2337/dc23-Sint", "PMC9810461", "36507647"]}, {"Citation": "Patel D.K., Kumarm R., Laloo D., Hemalatha S. Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pac. J. Trop. Dis. 2012;2:239\u2013250. doi: 10.1016/S2222-1808(12)60054-1.", "ArticleIdList": ["10.1016/S2222-1808(12)60054-1", "PMC3609313", "23569941"]}, {"Citation": "Chaturvedi R., Desai C., Patel P., Shah A., Dikshit R.K. An evaluation of the impact of antidiabetic medication on treatment satisfaction and quality of life in patients of diabetes mellitus. Perspect. Clin. Res. 2018;9:15\u201322.", "ArticleIdList": ["PMC5799947", "29430413"]}, {"Citation": "Gale E.A. Collateral damage: The conundrum of drug safety. Diabetologia. 2009;52:1975\u20131982. doi: 10.1007/s00125-009-1491-8.", "ArticleIdList": ["10.1007/s00125-009-1491-8", "19688335"]}, {"Citation": "Tran N., Pham B., Le L. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery. Biology. 2020;9:252. doi: 10.3390/biology9090252.", "ArticleIdList": ["10.3390/biology9090252", "PMC7563488", "32872226"]}, {"Citation": "Hannan J.M., Ali L., Rokeya B., Khaleque J., Akhter M., Flatt P.R., Abdel-Wahab Y.H. Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br. J. Nutr. 2007;97:514\u2013521. doi: 10.1017/S0007114507657869.", "ArticleIdList": ["10.1017/S0007114507657869", "17313713"]}, {"Citation": "Xue W.L., Li X.S., Zhang J., Liu Y.H., Wang Z.L., Zhang R.J. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asian Pac. J. Clin. Nutr. 2007;16:422\u2013426.", "ArticleIdList": ["17392143"]}, {"Citation": "Rafraf M., Malekiyan M., Asghari-Jafarabadi M., Aliasgarzadeh A. Effect of Fenugreek Seeds on Serum Metabolic Factors and Adiponectin Levels in Type 2 Diabetic Patients. Int. J. Vitam. Nutr. Res. 2014;84:196\u2013205. doi: 10.1024/0300-9831/a000206.", "ArticleIdList": ["10.1024/0300-9831/a000206", "26098483"]}, {"Citation": "Verma N., Usman K., Patel N., Jain A., Dhakre S., Swaroop A., Bagchi M., Kumar P., Preuss H.G., Bagchi D. A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro\u2122) in patients with type 2 diabetes. Food Nutr. Res. 2016;60:32382. doi: 10.3402/fnr.v60.32382.", "ArticleIdList": ["10.3402/fnr.v60.32382", "PMC5061863", "27733237"]}, {"Citation": "Ranade M., Mudgalkar N. A simple dietary addition of fenugreek seed leads to the reduction in blood glucose levels: A parallel group, randomized single-blind trial. Ayu. 2017;38:24\u201327. doi: 10.4103/ayu.AYU_209_15.", "ArticleIdList": ["10.4103/ayu.AYU_209_15", "PMC5954247", "29861588"]}, {"Citation": "Anand P., Murali K.Y., Tandon V., Murthy P.S., Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem. Biol. Interact. 2010;186:72\u201381. doi: 10.1016/j.cbi.2010.03.044.", "ArticleIdList": ["10.1016/j.cbi.2010.03.044", "20363216"]}, {"Citation": "Yaghmoor S.S., Khoja S.M. Effect of cinnamon on plasma glucose concentration and the regulation of 6-phosphofructo-1-kinase activity from the liver and small intestine of streptozotocin induced diabetic rats. J. Biol. Sci. 2010;10:761\u2013766. doi: 10.3923/jbs.2010.761.766.", "ArticleIdList": ["10.3923/jbs.2010.761.766"]}, {"Citation": "Khan A., Safdar M., Ali Khan M.M., Khattak K.N., Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215\u20133218. doi: 10.2337/diacare.26.12.3215.", "ArticleIdList": ["10.2337/diacare.26.12.3215", "14633804"]}, {"Citation": "Khan R., Khan Z., Shah S.H. Cinnamon May Reduce Glucose, Lipid and Cholesterol Level in Type 2 Diabetic Individuals. Pak. J. Nutr. 2010;9:430\u2013433. doi: 10.3923/pjn.2010.430.433.", "ArticleIdList": ["10.3923/pjn.2010.430.433"]}, {"Citation": "Akilen R., Tsiami A., Devendra D., Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: A randomized, placebo-controlled, double-blind clinical trial. Diabet. Med. 2010;27:1159\u20131167. doi: 10.1111/j.1464-5491.2010.03079.x.", "ArticleIdList": ["10.1111/j.1464-5491.2010.03079.x", "20854384"]}, {"Citation": "Jain S.K., Rains J., Croad J., Larson B., Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid. Redox Signal. 2009;11:241\u2013249. doi: 10.1089/ars.2008.2140.", "ArticleIdList": ["10.1089/ars.2008.2140", "PMC2933148", "18976114"]}, {"Citation": "Seo K.I., Choi M.S., Jung U.J., Kim H.J., Yeo J., Jeon S.M., Lee M.K. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res. 2008;52:995\u20131004. doi: 10.1002/mnfr.200700184.", "ArticleIdList": ["10.1002/mnfr.200700184", "18398869"]}, {"Citation": "Na L.X., Li Y., Pan H.Z., Zhou X.L., Sun D.J., Meng M., Li X.X., Sun C.H. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: A double-blind, placebo-controlled trial. Mol. Nutr. Food Res. 2013;57:1569\u20131577. doi: 10.1002/mnfr.201200131.", "ArticleIdList": ["10.1002/mnfr.201200131", "22930403"]}, {"Citation": "Rahimi H.R., Mohammadpour A.H., Dastani M., Jaafari M.R., Abnous K., Mobarhan M.G., Oskuee R.K. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna J. Phytomed. 2016;6:567\u2013577.", "ArticleIdList": ["PMC5052420", "27761427"]}, {"Citation": "Asadi S., Gholami M.S., Siassi F., Qorbani M., Khamoshian K., Sotoudeh G. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complement. Ther. Med. 2019;43:253\u2013260. doi: 10.1016/j.ctim.2019.02.014.", "ArticleIdList": ["10.1016/j.ctim.2019.02.014", "30935539"]}, {"Citation": "Kong W.J., Zhang H., Song D.Q., Xue R., Zhao W., Wei J., Wang Y.M., Shan N., Zhou Z.X., Yang P., et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2009;58:109\u2013119. doi: 10.1016/j.metabol.2008.08.013.", "ArticleIdList": ["10.1016/j.metabol.2008.08.013", "19059538"]}, {"Citation": "Zhang W., Xu Y.C., Guo F.J., Meng Y., Li M.L. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin. Med. J. 2008;121:2124\u20132128. doi: 10.1097/00029330-200811010-00003.", "ArticleIdList": ["10.1097/00029330-200811010-00003", "19080170"]}, {"Citation": "Yin J., Xing H., Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57:712\u2013717. doi: 10.1016/j.metabol.2008.01.013.", "ArticleIdList": ["10.1016/j.metabol.2008.01.013", "PMC2410097", "18442638"]}, {"Citation": "Zhang H., Wei J., Xue R., Wu J.D., Zhao W., Wang Z.Z., Wang S.K., Zhou Z.X., Song D.Q., Wang Y.M., et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285\u2013292. doi: 10.1016/j.metabol.2009.07.029.", "ArticleIdList": ["10.1016/j.metabol.2009.07.029", "19800084"]}, {"Citation": "Rashidi H., Namjoyan F., Mehraban Z., Zakerkish M., Ghaderian S.B., Latifi S.M. The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients. Jundishapur J. Nat. Pharm. Prod. 2018;13:e64180. doi: 10.5812/jjnpp.64180.", "ArticleIdList": ["10.5812/jjnpp.64180"]}, {"Citation": "Ali A.M., Moqbel M.S., Al-Hizab F.A. Effect of momordica charantia on insulin immune-reactive pancreatic beta cells and blood glucose levels in streptozotocin-induced diabetic rats. J. Nutr. Sci. Vitaminol. 2022;68:438\u2013445. doi: 10.3177/jnsv.68.438.", "ArticleIdList": ["10.3177/jnsv.68.438", "36310078"]}, {"Citation": "Elekofehinti O.O., Oyedokun V.O., Iwaloye O., Lawal A.O., Ejelonu O.C. Momordica charantia silver nanoparticles modulate SOCS/JAK/STAT and P13K/Akt/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats. J. Diabetes Metab. Disord. 2021;20:245\u2013260. doi: 10.1007/s40200-021-00739-w.", "ArticleIdList": ["10.1007/s40200-021-00739-w", "PMC8212297", "34178835"]}, {"Citation": "Lim S.T., Jimeno C.A., Razon-Gonzales E.B., Velasquez M.E.N. The MOCHA DM study: The effect of Momordica charantia tablets on glucose and insulin levels during the postprandial state among patients with type 2 diabetes mellitus. Phillippine J. Intern. Med. 2010;48:19\u201325."}, {"Citation": "Cortez-Navarrete M., Mart\u00ednez-Abundis E., P\u00e9rez-Rubio K.G., Gonz\u00e1lez-Ortiz M., M\u00e9ndez-Del Villar M. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus. J. Med. Food. 2018;21:672\u2013677. doi: 10.1089/jmf.2017.0114.", "ArticleIdList": ["10.1089/jmf.2017.0114", "29431598"]}, {"Citation": "Kim S.K., Jung J., Jung J.H., Yoon N., Kang S.S., Roh G.S., Hahm J.R. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus. Complement. Ther. Med. 2020;52:102524. doi: 10.1016/j.ctim.2020.102524.", "ArticleIdList": ["10.1016/j.ctim.2020.102524", "32951763"]}, {"Citation": "Visuvanathan T., Than L.T.L., Stanslas J., Chew S.Y., Vellasamy S. Revisiting Trigonella foenum-graecum L. Pharmacology and Therapeutic Potentialities. Plants. 2022;11:1450. doi: 10.3390/plants11111450.", "ArticleIdList": ["10.3390/plants11111450", "PMC9182856", "35684222"]}, {"Citation": "Geberemeskel G.A., Debebe Y.G., Nguse N.A. Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients. J. Diabetes Res. 2019;2019:8507453. doi: 10.1155/2019/8507453.", "ArticleIdList": ["10.1155/2019/8507453", "PMC6748210", "31583253"]}, {"Citation": "Fuller S., Stephens J.M. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: Mechanisms of actions and potential effects on metabolic syndrome. Adv. Nutr. 2015;6:189\u2013197. doi: 10.3945/an.114.007807.", "ArticleIdList": ["10.3945/an.114.007807", "PMC4352177", "25770257"]}, {"Citation": "Gad M.Z., El-Sawalhi M.M., Ismail M.F., El-Tanbouly N.D. Biochemical study of the anti-diabetic action of the Egyptian plants fenugreek and balanites. Mol. Cell. Biochem. 2006;281:173\u2013183. doi: 10.1007/s11010-006-0996-4.", "ArticleIdList": ["10.1007/s11010-006-0996-4", "16328970"]}, {"Citation": "Al-Habori M., Raman A., Lawrence M.J., Skett P. In vitro effect of fenugreek extracts on intestinal sodium-dependent glucose uptake and hepatic glycogen phosphorylase A. Int. J. Exp. Diabetes Res. 2001;2:91\u201399. doi: 10.1155/EDR.2001.91.", "ArticleIdList": ["10.1155/EDR.2001.91", "PMC2478541", "12369721"]}, {"Citation": "Madar Z. Fenugreek (Trigonella foenum-graecum) as a means of reducing postprandial glucose level in diabetic rats. Nutr. Rep. Int. 1989;29:1267\u20131273."}, {"Citation": "Raju J., Gupta D., Rao A.R., Yadava P.K., Baquer N.Z. Trigonellafoenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol. Cell. Biochem. 2001;224:45\u201351. doi: 10.1023/A:1011974630828.", "ArticleIdList": ["10.1023/A:1011974630828", "11693199"]}, {"Citation": "Sauvaire Y., Petit P., Broca C., Manteghetti M., Baissac Y., Fernandez-Alvarez J., Gross R., Roye M., Leconte A., Gomis R., et al. 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes. 1998;47:206\u2013210. doi: 10.2337/diab.47.2.206.", "ArticleIdList": ["10.2337/diab.47.2.206", "9519714"]}, {"Citation": "Hillaire-Buys D., Petit P., Manteghetti M., Baissac Y., Sauvaire Y., Ribes G. A recently identified substance extracted from fenugreek seeds stimulates insulin secretion in rat. Diabetologia. 1993;36:A119."}, {"Citation": "Ribes G., Sauvaire Y., Costa C.D., Baccou J.C., Loubatieres-Mariani M.M. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proc. Soc. Exp. Biol. Med. 1986;182:159\u2013166. doi: 10.3181/00379727-182-42322.", "ArticleIdList": ["10.3181/00379727-182-42322", "2871558"]}, {"Citation": "King K., Lin N.P., Cheng Y.H., Chen G.H., Chein R.J. Isolation of Positive Modulator of Glucagon-like Peptide-1 Signaling from Trigonella foenum-graecum (Fenugreek) Seed. J. Biol. Chem. 2015;290:26235\u201326248. doi: 10.1074/jbc.M115.672097.", "ArticleIdList": ["10.1074/jbc.M115.672097", "PMC4646272", "26336108"]}, {"Citation": "Vijayakumar M.V., Singh S., Chhipa R.R., Bhat M.K. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br. J. Pharmacol. 2005;146:41\u201348. doi: 10.1038/sj.bjp.0706312.", "ArticleIdList": ["10.1038/sj.bjp.0706312", "PMC1576255", "15980869"]}, {"Citation": "Jaiswal N., Maurya C.K., Venkateswarlu K., Sukanya P., Srivastava A.K., Narender T., Tamrakar A.K. 4-Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells via phosphatidylinositol-3-kinase-dependent pathway. Eur. J. Nutr. 2012;51:893\u2013898. doi: 10.1007/s00394-012-0374-9.", "ArticleIdList": ["10.1007/s00394-012-0374-9", "22610671"]}, {"Citation": "Maurya C.K., Singh R., Jaiswal N., Venkateswarlu K., Narender T., Tamrakar A.K. 4-Hydroxyisoleucine ameliorates fatty acid-induced insulin resistance and inflammatory response in skeletal muscle cells. Mol. Cell. Endocrinol. 2014;395:51\u201360. doi: 10.1016/j.mce.2014.07.018.", "ArticleIdList": ["10.1016/j.mce.2014.07.018", "25109277"]}, {"Citation": "Yu H., Wu M., Lu F.R., Xie J., Zheng N., Qin Y., Gao F., Du W., Jian L.M. Effect of Trigonella foenum-graecum 4-hydroxyisoleucine on high-glucose induced insulin resistance in 3T3-L1 adipocytes of mice. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chin. J. Integr. Tradit. West. Med. 2013;33:1394\u20131399. (In Chinese)", "ArticleIdList": ["24432687"]}, {"Citation": "Bafadam S., Mahmoudabady M., Niazmand S., Rezaee S.A., Soukhtanloo M. Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats. J. Cardiovasc. Thorac. Res. 2021;13:28\u201336. doi: 10.34172/jcvtr.2021.01.", "ArticleIdList": ["10.34172/jcvtr.2021.01", "PMC8007891", "33815699"]}, {"Citation": "Singh P., Ishteyaque S., Prajapati R., Yadav K.S., Singh R., Kumar A., Sharma S., Narender T., Mugale M.N. Assessment of antidiabetic effect of 4-HIL in type 2 diabetic and healthy Sprague Dawley rats. Hum. Exp. Toxicol. 2022;41:9603271211061873. doi: 10.1177/09603271211061873.", "ArticleIdList": ["10.1177/09603271211061873", "35072544"]}, {"Citation": "Eidi A., Eidi M., Sokhteh M. Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Nutr. Res. 2007;27:728\u2013733. doi: 10.1016/j.nutres.2007.09.006.", "ArticleIdList": ["10.1016/j.nutres.2007.09.006"]}, {"Citation": "Gupta A., Gupta R., Lal B. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: A double blind placebo controlled study. J. Assoc. Phys. India. 2001;49:1057\u20131061.", "ArticleIdList": ["11868855"]}, {"Citation": "Najdi R.A., Hagras M.M., Kamel F.O., Magadmi R.M. A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes. Afr. Health. Sci. 2019;19:1594\u20131601. doi: 10.4314/ahs.v19i1.34.", "ArticleIdList": ["10.4314/ahs.v19i1.34", "PMC6531936", "31148988"]}, {"Citation": "Lu F.R., Shen L., Qin Y., Gao L., Li H., Dai Y. Clinical observation on Trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus. Chin. J. Integr. Med. 2008;14:56\u201360. doi: 10.1007/s11655-007-9005-3.", "ArticleIdList": ["10.1007/s11655-007-9005-3", "18219452"]}, {"Citation": "Sharma R.D., Raghuram T.C. Hypoglycaemic effect of fenugreek seeds in non-insulin dependent diabetic subjects. Nutr. Res. 1990;10:731\u2013739. doi: 10.1016/S0271-5317(05)80822-X.", "ArticleIdList": ["10.1016/S0271-5317(05)80822-X"]}, {"Citation": "Gaddam A., Galla C., Thummisetti S., Marikanty R.K., Palanisamy U.D., Rao P.V. Role of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. J. Diabetes Metab. Disord. 2015;14:74. doi: 10.1186/s40200-015-0208-4.", "ArticleIdList": ["10.1186/s40200-015-0208-4", "PMC4591578", "26436069"]}, {"Citation": "Ranasinghe P., Jayawardana R., Galappaththy P., Constantine G.R., de Vas Gunawardana N., Katulanda P. Efficacy and safety of \u2018true\u2019 cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: A systematic review and meta-analysis. Diabet. Med. 2012;29:1480\u20131492. doi: 10.1111/j.1464-5491.2012.03718.x.", "ArticleIdList": ["10.1111/j.1464-5491.2012.03718.x", "22671971"]}, {"Citation": "Sharma S., Mandal A., Kant R., Jachak S., Jagzape M. Is cinnamon efficacious for glycaemic control in type-2 diabetes mellitus? J. Pak. Med. Assoc. 2020;70:2065\u20132069.", "ArticleIdList": ["33341863"]}, {"Citation": "Beejmohun V., Peytavy-Izard M., Mignon C., Muscente-Paque D., Deplanque X., Ripoll C., Chapal N. Acute effect of Ceylon cinnamon extract on postprandial glycemia: Alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers. BMC. Complement. Altern. Med. 2014;14:351. doi: 10.1186/1472-6882-14-351.", "ArticleIdList": ["10.1186/1472-6882-14-351", "PMC4246455", "25249234"]}, {"Citation": "Vangalapati M., Satya N., Prakash D.V., Avanigadda S. A review on pharmacological activities and clinical effects of Cinnamon species. Res. J. Pharm. Biol. Chem. Sci. 2012;3:653\u2013663."}, {"Citation": "Ulbricht C., Seamon E., Windsor R.C., Armbruester N., Bryan J.K., Costa D., Giese N., Gruenwald J., Iovin R., Isaac R., et al. An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2011;8:378\u2013454. doi: 10.3109/19390211.2011.627783.", "ArticleIdList": ["10.3109/19390211.2011.627783", "22432776"]}, {"Citation": "Jayaprakasha G.K., Rao L.J. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit. Rev. Food Sci. Nutr. 2011;51:547\u2013562. doi: 10.1080/10408391003699550.", "ArticleIdList": ["10.1080/10408391003699550", "21929331"]}, {"Citation": "Taher M., Abdul Majid F.A., Sarmidi M.R. A proanthocyanidin from cinnamomum zeylanicum stimulates phosphorylation of insulin receptor in 3T3-L1 adipocytes. J. Teknol. 2006;44:53\u201368. doi: 10.11113/jt.v44.385.", "ArticleIdList": ["10.11113/jt.v44.385"]}, {"Citation": "Adisakwattana S., Lerdsuwankij O., Poputtachai U., Minipun A., Suparpprom C. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal \u03b1-glucosidase and pancreatic \u03b1-amylase. Plant Foods Hum. Nutr. 2011;66:143\u2013148. doi: 10.1007/s11130-011-0226-4.", "ArticleIdList": ["10.1007/s11130-011-0226-4", "21538147"]}, {"Citation": "Ranilla L.G., Kwon Y.I., Apostolidis E., Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010;101:4676\u20134689. doi: 10.1016/j.biortech.2010.01.093.", "ArticleIdList": ["10.1016/j.biortech.2010.01.093", "20185303"]}, {"Citation": "Fernando I.T., Perera K.I., Athauda S.B.P., Sivakanesan R., Kumar N.S., Jayasinghe L. Heat stability of the in vitro inhibitory effect of spices on lipase, amylase, and glucosidase enzymes. Food Sci. Nutr. 2019;7:425\u2013432. doi: 10.1002/fsn3.797.", "ArticleIdList": ["10.1002/fsn3.797", "PMC6393038", "30847119"]}, {"Citation": "Mohamed Sham Shihabudeen H., Hansi Priscilla D., Thirumurugan K. Cinnamon extract inhibits \u03b1-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr. Metab. 2011;8:46. doi: 10.1186/1743-7075-8-46.", "ArticleIdList": ["10.1186/1743-7075-8-46", "PMC3155477", "21711570"]}, {"Citation": "Kannappan S., Jayaraman T., Rajasekar P., Ravichandran M.K., Anuradha C.V. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singap. Med. J. 2006;47:858\u2013863.", "ArticleIdList": ["16990960"]}, {"Citation": "Shen Y., Fukushima M., Ito Y., Muraki E., Hosono T., Seki T., Ariga T. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci. Biotechnol. Biochem. 2010;74:2418\u20132425. doi: 10.1271/bbb.100453.", "ArticleIdList": ["10.1271/bbb.100453", "21150113"]}, {"Citation": "Subash Babu P., Prabuseenivasan S., Ignacimuthu S. Cinnamaldehyde\u2014A potential antidiabetic agent. Phytomedicine. 2007;14:15\u201322. doi: 10.1016/j.phymed.2006.11.005.", "ArticleIdList": ["10.1016/j.phymed.2006.11.005", "17140783"]}, {"Citation": "Kim S.H., Choung S.Y. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Arch. Pharm. Res. 2010;33:325\u2013333. doi: 10.1007/s12272-010-0219-0.", "ArticleIdList": ["10.1007/s12272-010-0219-0", "20195835"]}, {"Citation": "Vijayakumar K., Prasanna B., Rengarajan R.L., Rathinam A., Velayuthaprabhu S., Vijaya Anand A. Anti-diabetic and hypolipidemic effects of Cinnamon cassia bark extracts: An in vitro, in vivo, and in silico approach. Arch. Physiol. Biochem. 2023;129:338\u2013348. doi: 10.1080/13813455.2020.1822415.", "ArticleIdList": ["10.1080/13813455.2020.1822415", "32985927"]}, {"Citation": "Vafa M., Mohammadi F., Shidfar F., Sormaghi M.S., Heidari I., Golestan B., Amiri F. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int. J. Prev. Med. 2012;3:531\u2013536.", "ArticleIdList": ["PMC3429799", "22973482"]}, {"Citation": "Lu T., Sheng H., Wu J., Cheng Y., Zhu J., Chen Y. Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr. Res. 2012;32:408\u2013412. doi: 10.1016/j.nutres.2012.05.003.", "ArticleIdList": ["10.1016/j.nutres.2012.05.003", "22749176"]}, {"Citation": "Anderson R.A., Zhan Z., Luo R., Guo X., Guo Q., Zhou J., Kong J., Davis P.A., Stoecker B.J. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. J. Tradit. Complement. Med. 2015;6:332\u2013336. doi: 10.1016/j.jtcme.2015.03.005.", "ArticleIdList": ["10.1016/j.jtcme.2015.03.005", "PMC5067830", "27774415"]}, {"Citation": "Zare R., Nadjarzadeh A., Zarshenas M.M., Shams M., Heydari M. Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial. Clin. Nutr. 2019;38:549\u2013556. doi: 10.1016/j.clnu.2018.03.003.", "ArticleIdList": ["10.1016/j.clnu.2018.03.003", "29605574"]}, {"Citation": "Talaei B., Amouzegar A., Sahranavard S., Hedayati M., Mirmiran P., Azizi F. Effects of cinnamon consumption on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetic patients. Nutrients. 2017;9:991. doi: 10.3390/nu9090991.", "ArticleIdList": ["10.3390/nu9090991", "PMC5622751", "28885566"]}, {"Citation": "Kocaadam B., \u015eanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr. 2017;57:2889\u20132895. doi: 10.1080/10408398.2015.1077195.", "ArticleIdList": ["10.1080/10408398.2015.1077195", "26528921"]}, {"Citation": "Pivari F., Mingione A., Brasacchio C., Soldati L. Curcumin and type 2 diabetes mellitus: Prevention and treatment. Nutrients. 2019;11:1837. doi: 10.3390/nu11081837.", "ArticleIdList": ["10.3390/nu11081837", "PMC6723242", "31398884"]}, {"Citation": "Jim\u00e9nez-Flores L.M., L\u00f3pez-Briones S., Mac\u00edas-Cervantes M.H., Ram\u00edrez-Emiliano J., P\u00e9rez-V\u00e1zquez V. A PPAR\u03b3, NF-\u03baB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver. Molecules. 2014;19:8289\u20138302. doi: 10.3390/molecules19068289.", "ArticleIdList": ["10.3390/molecules19068289", "PMC6271620", "24945581"]}, {"Citation": "Na L.X., Zhang Y.L., Li Y., Liu L.Y., Li R., Kong T., Sun C.H. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr. Metab. Cardiovasc. Dis. 2011;21:526\u2013533. doi: 10.1016/j.numecd.2009.11.009.", "ArticleIdList": ["10.1016/j.numecd.2009.11.009", "20227862"]}, {"Citation": "Picard F., Auwerx J. PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 2002;22:167\u2013197. doi: 10.1146/annurev.nutr.22.010402.102808.", "ArticleIdList": ["10.1146/annurev.nutr.22.010402.102808", "12055342"]}, {"Citation": "Cheng T.C., Lin C.S., Hsu C.C., Chen L.J., Cheng K.C., Cheng J.T. Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. Neurosci. Lett. 2009;465:238\u2013241. doi: 10.1016/j.neulet.2009.09.012.", "ArticleIdList": ["10.1016/j.neulet.2009.09.012", "19765405"]}, {"Citation": "El-Moselhy M.A., Taye A., Sharkawi S.S., El-Sisi S.F., Ahmed A.F. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids. Food Chem. Toxicol. 2011;49:1129\u20131140. doi: 10.1016/j.fct.2011.02.004.", "ArticleIdList": ["10.1016/j.fct.2011.02.004", "21310207"]}, {"Citation": "Adibian M., Hodaei H., Nikpayam O., Sohrab G., Hekmatdoost A., Hedayati M. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother. Res. 2019;33:1374\u20131383. doi: 10.1002/ptr.6328.", "ArticleIdList": ["10.1002/ptr.6328", "30864188"]}, {"Citation": "Shafabakhsh R., Asemi Z., Reiner Z., Soleimani A., Aghadavod E., Bahmani F. The effects of nano-curcumin on metabolic status in patients with diabetes on hemodialysis, a randomized, double blind, placebo-controlled trial. Iran. J. Kidney Dis. 2020;14:290\u2013299.", "ArticleIdList": ["32655024"]}, {"Citation": "Hodaei H., Adibian M., Nikpayam O., Hedayati M., Sohrab G. The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetol. Metab. Syndr. 2019;11:41. doi: 10.1186/s13098-019-0437-7.", "ArticleIdList": ["10.1186/s13098-019-0437-7", "PMC6537430", "31149032"]}, {"Citation": "Adab Z., Eghtesadi S., Vafa M.R., Heydari I., Shojaii A., Haqqani H., Arablou T., Eghtesadi M. Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytother. Res. 2019;33:1173\u20131181. doi: 10.1002/ptr.6312.", "ArticleIdList": ["10.1002/ptr.6312", "30859660"]}, {"Citation": "Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35:2121\u20132127. doi: 10.2337/dc12-0116.", "ArticleIdList": ["10.2337/dc12-0116", "PMC3476912", "22773702"]}, {"Citation": "Ai X., Yu P., Peng L., Luo L., Liu J., Li S., Lai X., Luan F., Meng X. Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front. Pharmacol. 2021;12:762654. doi: 10.3389/fphar.2021.762654.", "ArticleIdList": ["10.3389/fphar.2021.762654", "PMC8964367", "35370628"]}, {"Citation": "Suadoni M.T., Atherton I. Berberine for the treatment of hypertension: A systematic review. Complement. Ther. Clin. Pract. 2021;42:101287. doi: 10.1016/j.ctcp.2020.101287.", "ArticleIdList": ["10.1016/j.ctcp.2020.101287", "33461163"]}, {"Citation": "Yin J., Ye J., Jia W. Effects and mechanisms of berberine in diabetes treatment. Acta Pharm. Sin. B. 2012;2:327\u2013334. doi: 10.1016/j.apsb.2012.06.003.", "ArticleIdList": ["10.1016/j.apsb.2012.06.003"]}, {"Citation": "Yang J., Yin J., Gao H., Xu L., Wang Y., Xu L., Li M. Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Evid. Based Complement. Altern. Med. 2012;2012:363845. doi: 10.1155/2012/363845.", "ArticleIdList": ["10.1155/2012/363845", "PMC3310165", "22474499"]}, {"Citation": "Yin J., Gao Z., Liu D., Liu Z., Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am. J. Physiol.-Endocrinol. Metab. 2008;294:E148\u2013E156. doi: 10.1152/ajpendo.00211.2007.", "ArticleIdList": ["10.1152/ajpendo.00211.2007", "PMC2464622", "17971514"]}, {"Citation": "Yu Y., Liu L., Wang X., Liu X., Liu X., Xie L., Wang G. Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies. Biochem. Pharmacol. 2010;79:1000\u20131006. doi: 10.1016/j.bcp.2009.11.017.", "ArticleIdList": ["10.1016/j.bcp.2009.11.017", "19945441"]}, {"Citation": "Liu L., Yu Y.L., Yang J.S., Li Y., Liu Y.W., Liang Y., Liu X.D., Xie L., Wang G.J. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedeberg\u2019s Arch. Pharmacol. 2010;381:371\u2013381. doi: 10.1007/s00210-010-0502-0.", "ArticleIdList": ["10.1007/s00210-010-0502-0", "20229011"]}, {"Citation": "Han J., Lin H., Huang W. Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med. Sci. Monit. 2011;17:RA164\u2013RA167. doi: 10.12659/MSM.881842.", "ArticleIdList": ["10.12659/MSM.881842", "PMC3539561", "21709646"]}, {"Citation": "Sun Y., Jin C., Zhang X., Jia W., Le J., Ye J. Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice. Nutr. Diabetes. 2018;8:53. doi: 10.1038/s41387-018-0061-x.", "ArticleIdList": ["10.1038/s41387-018-0061-x", "PMC6155143", "30250193"]}, {"Citation": "Xia X., Yan J., Shen Y., Tang K., Yin J., Zhang Y., Yang D., Liang H., Ye J., Weng J. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS ONE. 2011;6:e16556. doi: 10.1371/journal.pone.0016556.", "ArticleIdList": ["10.1371/journal.pone.0016556", "PMC3033390", "21304897"]}, {"Citation": "Zhao J.D., Li Y., Sun M., Yu C.J., Li J.Y., Wang S.H., Yang D., Guo C.L., Du X., Zhang W.J., et al. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats. World J. Gastroenterol. 2021;27:708\u2013724. doi: 10.3748/wjg.v27.i8.708.", "ArticleIdList": ["10.3748/wjg.v27.i8.708", "PMC7934002", "33716449"]}, {"Citation": "Wang D., Ren Y., Sun W., Gong J., Zou X., Dong H., Xu L., Wang K., Lu F. Berberine Ameliorates Glucose Metabolism in Diabetic Rats through the alpha7 Nicotinic Acetylcholine Receptor-Related Cholinergic Anti-Inflammatory Pathway. Planta Med. 2022;88:33\u201342. doi: 10.1055/a-1385-8015.", "ArticleIdList": ["10.1055/a-1385-8015", "33682914"]}, {"Citation": "Chen Y., Wang Y., Zhang J., Sun C., Lopez A. Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance. ISRN. Endocrinol. 2011;2011:519371. doi: 10.5402/2011/519371.", "ArticleIdList": ["10.5402/2011/519371", "PMC3262646", "22363882"]}, {"Citation": "Wang Y., Liu H., Zheng M., Yang Y., Ren H., Kong Y., Wang S., Wang J., Jiang Y., Yang J., et al. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. Front. Endocrinol. 2021;12:609134. doi: 10.3389/fendo.2021.609134.", "ArticleIdList": ["10.3389/fendo.2021.609134", "PMC8138858", "34025574"]}, {"Citation": "Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., Huo L., Wang M., Hong J., Wu P., et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J. Clin. Endocrinol. Metab. 2008;93:2559\u20132565. doi: 10.1210/jc.2007-2404.", "ArticleIdList": ["10.1210/jc.2007-2404", "18397984"]}, {"Citation": "Zhang Y., Gu Y., Ren H., Wang S., Zhong H., Zhao X., Ma J., Gu X., Xue Y., Huang S., et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) Nat. Commun. 2020;11:5015. doi: 10.1038/s41467-020-18414-8.", "ArticleIdList": ["10.1038/s41467-020-18414-8", "PMC7538905", "33024120"]}, {"Citation": "Harrison S.A., Gunn N., Neff G.W., Kohli A., Liu L., Flyer A., Goldkind L., Di Bisceglie A.M. A phase 2 proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nat. Commun. 2021;12:5503. doi: 10.1038/s41467-021-25701-5.", "ArticleIdList": ["10.1038/s41467-021-25701-5", "PMC8448729", "34535644"]}, {"Citation": "Di Pierro F., Villanova N., Agostini F., Marzocchi R., Soverini V., Marchesini G. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab. Syndr. Obes. 2012;5:213\u2013217. doi: 10.2147/DMSO.S33718.", "ArticleIdList": ["10.2147/DMSO.S33718", "PMC3422905", "22924000"]}, {"Citation": "Sur S., Ray R.B. Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy. Cancers. 2020;12:2064. doi: 10.3390/cancers12082064.", "ArticleIdList": ["10.3390/cancers12082064", "PMC7464160", "32726914"]}, {"Citation": "Cortez-Navarrete M., M\u00e9ndez-Del Villar M., Ramos-Gonz\u00e1lez E.J., P\u00e9rez-Rubio K.G. Momordica Charantia: A Review of Its Effects on Metabolic Diseases and Mechanisms of Action. J. Med. Food. 2021;24:1017\u20131027. doi: 10.1089/jmf.2020.0206.", "ArticleIdList": ["10.1089/jmf.2020.0206", "33733863"]}, {"Citation": "Tan S.P., Kha T.C., Parks S.E., Roach P.D. Bitter melon (Momordica charantia L.) bioactive composition and health benefits: A review. Food Rev. Int. 2016;32:181\u2013202. doi: 10.1080/87559129.2015.1057843.", "ArticleIdList": ["10.1080/87559129.2015.1057843"]}, {"Citation": "Kumar Shetty A., Suresh Kumar G., Veerayya Salimath P. Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol. Nutr. Food. Res. 2005;49:791\u2013796. doi: 10.1002/mnfr.200500035.", "ArticleIdList": ["10.1002/mnfr.200500035", "16007724"]}, {"Citation": "Nhiem N.X., Kiem P.V., Minh C.V., Ban N.K., Cuong N.X., Tung N.H., Ha L.M., Ha D.T., Tai B.H., Quang T.H., et al. Alpha-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Chem. Pharm. Bull. 2010;58:720\u2013724. doi: 10.1248/cpb.58.720.", "ArticleIdList": ["10.1248/cpb.58.720", "20460803"]}, {"Citation": "Ahmed I., Adeghate E., Cummings E., Sharma A.K., Singh J. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol. Cell. Biochem. 2004;261:63\u201370. doi: 10.1023/B:MCBI.0000028738.95518.90.", "ArticleIdList": ["10.1023/B:MCBI.0000028738.95518.90", "15362486"]}, {"Citation": "Rathi S.S., Grover J.K., Vats V. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother. Res. 2002;16:236\u2013243. doi: 10.1002/ptr.842.", "ArticleIdList": ["10.1002/ptr.842", "12164268"]}, {"Citation": "Fernandes N.P., Lagishetty C.V., Panda V.S., Naik S.R. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC. Complement. Altern. Med. 2007;7:29. doi: 10.1186/1472-6882-7-29.", "ArticleIdList": ["10.1186/1472-6882-7-29", "PMC2048984", "17892543"]}, {"Citation": "Shibib B.A., Khan L.A., Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J. 1993;292:267\u2013270.", "ArticleIdList": ["PMC1134299", "8389127"]}, {"Citation": "Tan M.J., Ye J.M., Turner N., Hohnen-Behrens C., Ke C.Q., Tang C.P., Chen T., Weiss H.C., Gesing E.R., Rowland A., et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 2008;15:263\u2013273. doi: 10.1016/j.chembiol.2008.01.013.", "ArticleIdList": ["10.1016/j.chembiol.2008.01.013", "18355726"]}, {"Citation": "Shih C.C., Lin C.H., Lin W.L., Wu J.B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J. Ethnopharmacol. 2009;123:82\u201390. doi: 10.1016/j.jep.2009.02.039.", "ArticleIdList": ["10.1016/j.jep.2009.02.039", "19429344"]}, {"Citation": "Shih C.C., Lin C.H., Lin W.L. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res. Clin. Pract. 2008;81:134\u2013143. doi: 10.1016/j.diabres.2008.04.023.", "ArticleIdList": ["10.1016/j.diabres.2008.04.023", "18550200"]}, {"Citation": "Sridhar M.G., Vinayagamoorthi R., Arul Suyambunathan V., Bobby Z., Selvaraj N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br. J. Nutr. 2008;99:806\u2013812. doi: 10.1017/S000711450783176X.", "ArticleIdList": ["10.1017/S000711450783176X", "17942003"]}, {"Citation": "Klomann S.D., Mueller A.S., Pallauf J., Krawinkel M.B. Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice. Br. J. Nutr. 2010;104:1613\u20131620. doi: 10.1017/S0007114510002680.", "ArticleIdList": ["10.1017/S0007114510002680", "20615270"]}, {"Citation": "Bhat G.A., Khan H.A., Alhomida A.S., Sharma P., Singh R., Paray B.A. GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia. BMC. Complement. Altern. Med. 2018;18:162. doi: 10.1186/s12906-018-2252-3.", "ArticleIdList": ["10.1186/s12906-018-2252-3", "PMC5960212", "29776414"]}, {"Citation": "Hafizur R.M., Kabir N., Chishti S. Modulation of pancreatic \u03b2-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Nat. Prod. Res. 2011;25:353\u2013367. doi: 10.1080/14786411003766904.", "ArticleIdList": ["10.1080/14786411003766904", "21328131"]}, {"Citation": "Abdollahi M., Zuki A.B., Goh Y.M., Rezaeizadeh A., Noordin M.M. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats. Histol. Histopathol. 2011;26:13\u201321.", "ArticleIdList": ["21117023"]}, {"Citation": "Singh N., Gupta M. Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian. J. Exp. Biol. 2007;45:1055\u20131062.", "ArticleIdList": ["18254212"]}, {"Citation": "Hussain F., Hafeez J., Khalifa A.S., Naeem M., Ali T., Eed E.M. In vitro and in vivo study of inhibitory potentials of \u03b1-glucosidase and acetylcholinesterase and biochemical profiling of M. charantia in alloxan-induced diabetic rat models. Am. J. Transl. Res. 2022;14:3824\u20133839.", "ArticleIdList": ["PMC9274573", "35836841"]}, {"Citation": "Makena W., Hambolu J.O., Timbuak J.A., Umana U.E., Iliya A.I., Dibal N.I. Mormodica charantia L. fruit and Genistein ameliorates type 2 diabetes in rats by preventing lipid accumulation, insulin resistance and enhancing beta cell function. J. Diabetes Metab. Disord. 2020;19:1303\u20131310. doi: 10.1007/s40200-020-00648-4.", "ArticleIdList": ["10.1007/s40200-020-00648-4", "PMC7843820", "33553029"]}, {"Citation": "Rahman I.U., Khan R.U., Rahman K.U., Bashir M. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutr. J. 2015;14:13. doi: 10.1186/1475-2891-14-13.", "ArticleIdList": ["10.1186/1475-2891-14-13", "PMC4417309", "25623883"]}, {"Citation": "Suthar A.C., Deshmukh A., Babu V., Mohan V.S., Chavan M.V., Kumar D., Chauhan V., Sharma S., Sharma M. Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: An open label, randomized, active controlled, phase II trial. Clin. Diabetol. 2016;5:88\u201394. doi: 10.5603/DK.2016.0015.", "ArticleIdList": ["10.5603/DK.2016.0015"]}, {"Citation": "Krawinkel M.B., Ludwig C., Swai M.E., Yang R.Y., Chun K.P., Habicht S.D. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. J. Ethnopharmacol. 2018;216:1\u20137. doi: 10.1016/j.jep.2018.01.016.", "ArticleIdList": ["10.1016/j.jep.2018.01.016", "29339109"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "3", "Day": "25"}, {"Year": "2023", "Month": "3", "Day": "28"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "4", "Day": "28", "Hour": "1", "Minute": "45"}, {"Year": "2023", "Month": "3", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["37111272", "PMC10145167", "10.3390/ph16040515", "ph16040515"]}}], "PubmedBookArticle": []}